HTA105 Use of Real-World Evidence to Support Direct Oral Anti-Coagulant Reimbursement and Implementation in Atrial Fibrillation. a Comparison of Experiences in Three Markets
Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.2671
https://www.valueinhealthjournal.com/article/S1098-3015(23)02861-9/fulltext
Title :
HTA105 Use of Real-World Evidence to Support Direct Oral Anti-Coagulant Reimbursement and Implementation in Atrial Fibrillation. a Comparison of Experiences in Three Markets
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)02861-9&doi=10.1016/j.jval.2023.03.2671
First page :
Section Title :
Open access? :
No
Section Order :
10930